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 The mitochondrion’s energy-transducing inner membrane is home to the electron 
transport chain, a meshwork of protein complexes vital to maintaining cellular energy balance. The 
unique lipid composition of the inner membrane of the mitochondrion includes the dimeric 
phospholipid, cardiolipin, which is vital for the efficient activity of respiratory Complex IV, the 
terminal member of the electron transport chain. Previous studies have investigated the protein-
lipid interaction between respiratory Complex IV and cardiolipin in detergent micelles and found 
endogenous cardiolipin molecules, which co-purified with the protein. In this study, respiratory 
Complex IV was purified and the endogenous cardiolipin molecules were removed with porcine 
phospholipase A2, before being incorporated into the biologically relevant nanodisc model 
membrane system. The cardiolipin-free respiratory Complex IV was reconstituted into a controlled 
lipid environment containing the bilayer favoring phospholipid POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine) or a biomimetic mixture of lipids, including POPC, POPE (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine) and tetraoleoyl cardiolipin, in molar ratios similar to 
the lipid environment found in the inner mitochondrial membrane. Using this model system, it has 
been shown that cardiolipin is vital for the proper activity of respiratory Complex IV. Moreover, 
this work provides initial evidence that cardiolipin contributes to the activity of Complex IV 
through the presence bulk lipids that do not directly interface with Complex IV as annular lipids. 
These findings are significant, as they provide insight into the pathology of diseases associated 





The mitochondrion is a eukaryotic organelle that is vital to energy transduction in the cell. The 
biochemical processes associated with oxidative phosphorylation, the citric acid cycle and electron 
transport chain are both present in the mitochondrion. The unique structure of the mitochondrion 
(Figure 1) is defined by two unique membranes, which define three separate spaces (1). The energy 
conserving inner mitochondrial membrane, marked by uniquely shaped cristae, surrounds the 
mitochondrial matrix, an aqueous compartment that is the site of the citric acid cycle and many other 
biochemical processes. The lipid composition of the inner mitochondrial membrane is 30-40 percent 
phosphatidylcholine (PC), 30-40 percent phosphatidylethanolamine (PE), and 15-20 percent cardiolipin 
(2). The inner mitochondrial membrane also contains other lipids, such as phosphatidylserine, 
phosphatidylinositol, sterols, and sphingolipids, in much lower molar amounts. The intermembrane 
space is contained within the inner and outer mitochondrial membranes and is much more acidic than 
the matrix. The porous outer mitochondrial membrane delineates the organelle from the cytoplasm of 
the cell.  
 
 
The mitochondrion is well known for being the powerhouse of the cell, and in addition to maintaining 
cellular energy balance, is responsible for many vital cellular processes such as the production of 
precursors to biological macromolecules, the initiation of apoptosis, and the generation of reactive 
Figure 1 – The Structure of the Mitochondrion 
A. A cartoon representation of the mitochondrion B. An electron micrograph of mitochondria 
in HeLa cells. Adapted from Sun et. al.(31). 
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oxygen species used in cellular signaling pathways (1). The unique structure of the mitochondrion serves 
to optimize the unique roles that the organelle must carry out for optimal cell function. 
 The energy generating pathways of the mitochondrion converge on the inner mitochondrial 
membrane with the electron transport chain (Figure 2). The electron transport chain is fed by NADH and 
FADH2, electron carriers and products of the citric acid cycle. Electrons supplied to the electron 
transport chain are shuttled between respiratory complexes via electron carriers, until the electrons are 
transferred to molecular oxygen. The transfer of electrons between respiratory complexes is coupled 
with proton pumping from the matrix to the intermembrane space. The highly convoluted nature of 
cristae, which are enriched in electron transport complexes (3), increases the surface area of the 
membrane to increase the number of respiratory complexes embedded in the membrane and therefore 
the amount of ATP that can be generated. The inner mitochondrial membrane has one of the highest 
protein to lipid ratios observed in nature, with the membrane being composed of approximately 70% 
protein by weight (2). 
 
Figure 2 – A Diagram of the Mammalian Electron Transport Chain 
Core catalytic subunits of protein complexes are depicted in blue, while regulatory and supernumerary subunits 
are depicted in green. The flow of electrons is depicted in orange and the movement of protons across the inner 




Electrons from nucleotide electron carriers enter the electron transport chain through 
Complexes I and II (1). Respiratory Complex I (NADH: ubiquinone oxidoreductate) shuttles electrons 
from NADH to the quinone Coenzyme Q (Q), a lipid-soluble, hydrophobic electron carrier within the 
inner mitochondrial membrane. Complex I is found in metazoans, but not in yeast, where instead 
peripheral NADH dehydrogenases carry out the transfer of electrons from NADH to Q (4). The exergonic 
flux of electrons from  NADH to Q is used to drive four protons across the inner mitochondrial 
membrane. Respiratory Complex II (Succinate: ubiquinone oxidoreductase) is the only respiratory 
complex of the electron transport chain that is also a component of the Citric Acid Cycle, which catalyzes 
the oxidation of succinate to fumarate. The electrons generated by Complex II are used to reduce the 
quinone pool, just as Complex I does. The redox reactions mediated by Complex II are not sufficiently 
exergonic to be coupled with proton pumping; however, Complex II is still vital because of the role it 
plays in catalyzing an intermediate step in the Citric Acid Cycle, and in reducing the Q pool, as described 
above. If Complex II did not catalyze the oxidation of succinate, the citric acid cycle would halt, as would 
the regeneration of electron carriers to supply the electron transport chain. Respiratory Complex III 
(ubiquinone: cytochrome c oxidoreductase) transfers electrons from the QH2 pool, reduced by 
Complexes I and II, to cytochrome c. The electron transfer carried out by Complex III is unique because 
QH2 carries two electrons, whereas cytochrome c is only able to carry a single electron. In Complex III, 
the protein must accept two electrons from Coenzyme Q and individually transfer the electrons to 
cytochrome c. This electron transfer is thermodynamically favorable enough to be coupled with the 
translocation of four protons across the inner mitochondrial membrane. Cytochrome c is a peripheral 
membrane protein found in the intermembrane space and when released into the cytoplasm, this 
protein has peroxidase activity and initiates a signal cascade leading to apoptosis. The terminal enzyme 
of the electron transport chain, respiratory Complex IV (Cytochrome C Oxidase), transfers electrons 
from cytochrome c to molecular oxygen. This reaction produces water and is used to drive two protons 
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across the inner mitochondrial membrane for every electron transferred from cytochrome c (5-7). There 
are three channels suspected to act as pathways for the movement of protons in Complex IV. Two of the 
proton channels, known as the D and K channels, shuttle protons needed for the reduction of oxygen 
(7), while the third proton channel, known as the H channel, is suspected to provide a route for the 
translocation of protons across the inner mitochondrial membrane (5). Respiratory Complexes I, III, and 
IV all pump protons across the inner mitochondrial membrane, creating a chemiosmotic gradient across 
the insulating inner mitochondrial membrane. F0F1 ATP Synthase, often referred to as Complex V, 
harnesses the proton gradient across the membrane to generate ATP from ADP and Pi in a process 
termed oxidative phosphorylation. F0F1 ATP Synthase allows protons to flow down their electrochemical 
gradient, to drive conformational changes in the catalytic module. Specifically, a protein shaft rotates in 
ATP Synthase to force the catalytic subunits to adopt specific conformations, which result in the 
phosphorylation of ADP into ATP.   
 The inner mitochondrial membrane is enriched with the lipid cardiolipin, the signature 
phospholipid of energy transducing membranes (8, 9). Cardiolipin is also found bacterial membranes (8, 
9); therefore, mitochondrial enrichment of cardiolipin results from the endosymbiotic origin of the 
organelle. Based on the endosymbiotic theory, the mitochondria found in contemporary eukaryotic cells 
are derived from an ancestral prokaryote having energy transducing membranes containing cardiolipin 
(7). Cardiolipin (Figure 3) is a lipid dimer composed of two diacylglycerols that are linked via the 
phosphate headgroups by a glycerol bridge (9, 10). Cardiolipin contains four acyl chains, in contrast to 
other phospholipids that contain only two. There is still great debate in the literature over whether or 
not the pKa of the phosphates in cardiolipin are identical, or if the two phosphates have disparate pKa 
values due to the proposed bicyclic structure of the headgroups stabilized by hydrogen bonds (11, 12).  
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Cardiolipin is synthesized in the inner mitochondrial membrane through a lipid-remodeling pathway 
composed of several enzymes (9). Immediately following synthesis, nascent cardiolipin 
 
Figure 3 – The Structure and Distribution of Cardiolipin 
A. The structure of tetraoleoyl cardiolipin. B. The structure of the possible bicyclic headgroup of cardiolipin. DAG 
stands for diacylglycerol. C. A table adapted from Horvath and Daum (8) describing the lipid composition of 
biological membranes found in rat liver. 
contains saturated acyl chains and is converted to the mature form when the saturated acyl chains of 
immature cardiolipin are replaced with unsaturated acyl chains from PE or PC. The final acyl chain 
profile of mature cardiolipin is tissue-specific in metazoans, and may be related to the energy 
requirements of the tissue (9). The remodeling process has been well characterized in yeast, where acyl 
chains on immature cardiolipin are individually cleaved to form monolysocardiolipin, a cardiolipin 
molecule containing three acyl chains, by cardiolipin deacylase 1 (cld1) (9). The monolysocardiolipin is 
reacetylated by the tafazzin transacylase enzyme, which transfers acyl chains from donor phospholipids 
(9). After several rounds of remodeling, all of the saturated acyl chains on immature cardiolipin have 
been replaced with saturated acyl chains. Cardiolipin has been shown to play both a structural and 
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catalytic role with several of the respiratory complexes in the electron transport chain, such as 
Complexes II, III and IV (2, 10, 13, 14). Defects in cardiolipin remodeling can result in a number of 
pathologies, depending on which component of the remodeling pathway is affected. In Barth syndrome, 
the cardiolipin remodeling enzyme tafazzin is non-functional and results in gross abnormalities of the 
mitochondrial lipid profile, including reduced amounts of cardiolipin and increased monolysocardiolipin. 
Barth syndrome is characterized by a wide range of phenotypes, including cardiomyopathy, 
neutropenia, growth delay, muscle weakness and exercise intolerance (1, 9, 15). All of these symptoms 
stem from the reduced efficiency of the mitochondria, underscoring the important role that cardiolipin 
plays in mitochondrial function. Cardiolipin deficiency in the mitochondrial inner membrane is known to 
affect the fluidity and stability of the membrane with pronounced effects on the cristae membrane (3). 
 Borrowing from Jacques Monod’s comment on the unifying theme of biochemistry, “anything 
found to be true of E. coli must be true of elephants” (16), respiratory Complex IV has been structurally 
and functionally well characterized in both mammals, cattle (Bos tarus), and fungi, baker’s yeast 
(Saccharomyces cerevisiae). While there is high sequence homology between most of the subunits of 
Complex IV of the two species (5), there are some notable differences between the two holoenzymes; 
bovine Complex IV is composed of 13 subunits, whereas Complex IV found in yeast is only composed of 
11 subunits. Additionally, some isoforms of the accessory subunits of bovine Complex IV are often only 
expressed in specific tissues, while in yeast isoforms of one subunit are expressed depending on the 
availability of oxygen for the enzyme (1, 5). As both bovine and yeast Complex IV have been used to 
study the function Complex IV, it is important to reconcile discrepancies in nomenclature between the 
two models (Figure 4). For the purpose of clarity, all subunits will be referred to using the yeast 




Figure 4 –Homologous Subunits of Respiratory Complex IV 
Cox is an abbreviation of Cytochrome c Oxidase. *Cox5A and 5B are isoforms of the same subunit that are 
differentially expressed depending on the availability of oxygen. Adapted from the work of Marechal et. al. and 
Barrientos, et. al. (5, 17) 
Respiratory Complex IV is a chimera of protein subunits encoded by both nuclear and 
mitochondrial DNA. The protein subunits encoded by nuclear DNA accounts for more than 90% of all 
protein in the mitochondrion by weight (18). Mitochondrial DNA encodes a few highly conserved protein 
subunits of electron transport complexes, including the three core catalytic subunits of Complex IV, 
which contain the redox centers essential from function (6, 18). The remaining subunits are encoded by 
nuclear DNA, translated on cytoplasmic ribosomes and imported into mitochondria, where the subunits 
are assembled into a complete respiratory complex (1, 5). These subunits either stabilize or assist in the 
assembly of the complex. Cox1 contains three redox-active metal sites: heme a, heme a3, and a copper 
ion CuB (1, 5). Cox2 contains a binuclear copper site (5). Heme a3 is the site of oxygen binding and 
reduction upon electron transfer from cytochrome c (1, 6). Cox3 has no redox function, but is involved in 
the translocation of protons across the inner mitochondrial membrane (1, 6). Electrons transferred from 
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cytochrome c to Complex IV are first donated to Cua, then to heme a, before reducing oxygen at heme a3 
and CuB (1). Cyanide is a specific inhibitor of Complex IV and binds with extremely high affinity to the 
complex. Cyanide inserts between heme a3 and CuB (6), inducing a similar conformational change as 
oxygen upon binding. This prevents the flow of electrons and inhibits the catalytic activity of Complex IV 
(6).  
Respiratory Complex IV exists in vitro as a dimer (Figure 5), stabilized by several lipids including 
four cardiolipin molecules, two per monomer. Some of the cardiolipin molecules bind very tightly to 
Complex IV and co-purify with the complex (10, 13, 14, 19). Through x-ray crystallography studies, it has 
been shown that approximately two cardiolipin molecules that co-purify and co-crystalize per Complex 
IV monomer (6, 10, 14, 20). Numerous studies(14) and computer simulations (21) have shown that 
cardiolipin molecules interact in two positions per Complex IV; one site is in close proximity to the 
proton channels of Complex IV, while the other site is composed of bovine subunits VIa and VIb to form 
dimers of Complex IV (6, 10, 13, 14). The two sets of endogenous cardiolipin molecules bind with 
differing affinities to Complex IV (14, 22). One pair of low affinity cardiolipin molecules bind at the 
interface of the monomers and can be removed easily (13, 14, 21, 22). Complex IV is the rate-limiting 
enzyme of the electron transport chain and is regulated by hormones, lipids, and second messengers (1). 
In select tissues, a different isoform of bovine Complex IV, subunit VIa is expressed, which allosterically 
regulates the catalytic activity of the protein depending on the concentration of ATP and ADP (1, 5, 24).  
The loss of the weakly associated cardiolipin molecules from the protein complex results in the 
irreversible dissociation of bovine subunits VIa and VIb and is associated with the dissociation of the 
Complex IV dimer into monomers (13, 14). This dissociation has not been found to be associated with a 
loss of enzymatic activity of the protein, as work by Sedlak and Robinson has shown that it was possible 






Figure 5 – Crystal Structures of Bovine and Yeast Respiratory Complex IV 
Top (A) and side (B) views of dimeric and monomeric (C) bovine respiratory Complex IV co-crystalized with 
cardiolipin. Endogenous cardiolipin molecules have been labeled with red arrows and identified as having either 
low (L) or high (H) affinity for Complex IV. The core catalytic subunits have been colored blue, and the accessory 
subunits have been colored green. Accessory subunits found only in mammals and not in yeast have been colored 
yellow. COX VIa has been colored red. In C, some of the catalytic subunits have been removed to expose the redox 
metal centers. PDB ID: 2DYR (10) D. A superposition of the catalytic core of Bovine (grey) and yeast (colored) 
Complex IV, showing structural homology. E. Superposition of the redox centers found in the catalytic core of 
bovine and yeast. Figures 5D and 5E were adapted from Marechal et. al.(5) PDB ID: 1V54 
The second pair of cardiolipin molecules is tightly bound to Complex IV and is required for the 
proper activity of the protein (13, 14, 22). To remove the tightly bound cardiolipin molecules, Complex 
IV must be treated with phospholipase A2, which cleaves cardiolipin at the sn-2 position (23). Removal 
of the tightly bound endogenous cardiolipin molecules results in a 50 percent decrease in the electron 
transfer activity of the protein complex (5, 9, 13, 22). The tightly bound cardiolipin molecule was found 
to be located near the entrance to the D proton channel, and is believed to act as a proton antenna for 
Complex IV (14, 21). If cardiolipin truly has a bicyclic headgroup structure, then cardiolipin could 
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enhance the catalytic activity of Complex IV by donating protons that are held in the headgroup of the 
molecule. The decrease in activity associated with phospholipase treatment can be rescued by the 
addition of exogenous cardiolipin, which recovers more activity than any other lipid (9, 13). Complex IV 
treated with phospholipase has higher affinity for cardiolipin than any other lipid found in the inner 
mitochondrial membrane (13).  
In addition to stabilizing Complex IV dimers, cardiolipin is known to stabilize other respiratory 
complexes. Cardiolipin is important for the formation of respiratory supercomplexes, which in yeast, are 
composed of two monomers of Complex III and one to two monomers of Complex IV (1, 3, 4, 20). 
Supercomplexes improve the efficiency of oxidative phosphorylation by channeling cytochrome c 
between Complexes III and IV. Substrate channeling improves the efficiency of the transfer of electrons 
down the electron transport chain because the carriers are able to travel more directly between the 
different respiratory complexes, rather than relying purely on diffusion for the electron carriers to find 
the successive respiratory complex (4). Cardiolipin has been shown to improve the formation and 
stability of supercomplexes containing Respiratory Complexes III and IV (3, 4). In mammals, respiratory 
supercomplexes can also include Complex I (4, 20). Cardiolipin is believed to be the most important lipid 
of any respiratory supercomplex because it binds tightly to both Complex III and IV and therefore is 
believed to play a central role in respiratory supercomplex formation (4). Dissociation of respiratory 
supercomplexes is the result of decreased levels of cardiolipin and can result in numerous diseases and 
pathologies (4, 20). A reduction in the abundance of cardiolipin can be caused by oxidative stress from 
reactive oxygen species in the mitochondrion or by disorders in the cardiolipin remodeling pathway. 
The study of membrane proteins provides a technical challenge because membrane proteins are 
insoluble and have a propensity to aggregate (25, 26). The challenge arises from keeping the protein 
stable in an aqueous environment. Although several methods have been developed to allow for the 
study of membrane proteins in an aqueous environment, most of the traditional approaches result in 
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unstable membrane proteins in an environment that is non-biologically mimetic. One of the most 
common methods used to study membrane proteins is detergent solubilization. While this method is 
relatively quick and easy, it places membrane proteins in a micellar, not lamellar environment and can 
lead to inactivation of the protein over time. Detergent solubilization requires some optimization, as the 
detergent may denature the protein in question (25, 26). Another drawback to detergent solubilization 
is that it cannot be used to study protein-lipid interactions. Proteoliposomes are another popular 
technique employed to study membrane proteins, as this method allows for the study of the protein of 
interest in a lipid bilayer. This is achieved through the insertion of protein into the membrane of a 
liposome of defined lipid composition, assuming the lipid blend is able to form stable liposomes. This 
approach is biologically mimetic and creates an internal and external space that may be taken advantage 
of experimentally. Although the two discrete compartments can be useful, especially when gradients 
need to be established, proteoliposomes do not allow easy external access to the internal compartment. 
Proteoliposomes can be heterogeneously sized, introducing some variation into the experimental 
system. Additionally, proteoliposomes are large and scatter light, making liposomes poor candidates for 
use in spectrophotometric studies (25, 26). A relatively novel model membrane system is the nanodisc, a 
nanoscale lipid bilayer stabilized by an amphipathic protein scaffold into which the protein of interest 
can be inserted (25, 27). The size of the annular lipid bilayer is determined by the membrane scaffolding 
protein (MSP) (27), allowing for the creation of a homogenous model membrane system (2). Previous 
work from our group has shown that the nanodisc model membrane system is able to successfully 
incorporate mitochondrial membrane proteins (2). Nanodiscs are created using a reaction mixture 
containing the protein of interest in detergent micelles, membrane scaffolding protein and lipids. 
Nanodiscs will spontaneously form through the hydrophobic effect when the detergent is removed by 
adsorbent beads (26). The rate of nanodisc formation is dependent on the temperature and will occur 
most rapidly when the reaction occurs at a temperature near the melting temperature of the lipids in 
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the bilayer (26). Nanodiscs are especially useful for the study of protein-lipid interactions as any desired 
lipid blend that forms a stable bilayer can be used to reconstitute the protein.  
In this experiment, I aimed to elucidate the effect that cardiolipin has on the catalytic activity of 
respiratory Complex IV for the first time in a biologically mimetic model membrane system (Figure 6). 
This was achieved by purifying respiratory Complex IV out of mitochondria derived from S. cerevisiae 
and removing the endogenous cardiolipin with porcine phospholipase A2. The lipid-free Complex IV was 
incorporated into the nanodisc model membrane system containing lipid blends in which cardiolipin was 
either present or absent. The biomimetic (BM) lipid blends contained cardiolipin and were similar to the 
mitochondrial inner membrane (40 mole % POPC, 40 mole % POPE, and 20 mole % tetraoleoyl 
cardiolipin). The cardiolipin deficient samples contained only POPC. 
 
Figure 6 – Experimental Approach 
Please note, not all steps are shown. Catalytic subunits of protein complexes are depicted in blue, and regulatory 
and supernumerary subunits are depicted in green. Red subunits depict mutant Cox13 containing an affinity tag. 
Following phospholipase treatment, Cox13 dissociates from the protein complex, coinciding with the transition of 
Complex IV from the dimeric to monomeric state.  
 
Materials & Methods: 
Materials 
 Lipids were purchased form Avanti Polar Lipids (Alabaster, AL). Chemicals were obtained from 





 Our group engineered a hexahistidine tag onto the carboxyl terminus of Cox13 on respiratory 
Complex IV of S. cerevisiae, strain WT303-1A. The location of Cox13 has been depicted in red in Figures 
5A-C. The added affinity tag allows for the efficient purification of respiratory Complex IV via affinity 
purification on a Ni-NTA column. The hexahistidine tag was combined with the genetic sequence for 
kanamycin resistance and was targeted to the yeast genome through homologous recombination, as has 
been previously described (7). Work by Meunier et. al. has shown that engineering an affinity tag onto 
Complex IV has no effect on the catalytic activity of the protein.  
 
Mitochondria Growth and Preparation 
 Mitochondria were isolated from S. cerevisae, strain WT303-1A, engineered to contain an 
affinity tag on the carboxyl terminus of Cox13. Colonies of S. cerevisiae were grown on YEP Lactate + 
Adenine + Geneticin plates for three days. S. cerevisiae was grown from single colonies in successive 
overnight growth periods in increasing volumes of non-fermentable, undefined media SSLac (2% Na-
Lactate, 3 g/L yeast extract, 5.7 mM KH2PO4, 18.7 mM NH4Cl, 8.5 mM NaCl, 4.5 mM CaCl2, 2.9 mM 
MgCl2~6H2O, 2.7 mM D-(+) glucose, 170 µM Adenine Hemisulfate salt, and 250 µg/mL Geneticin, pH 
5.5). First, 5 mL culture tubes of SSLac were inoculated with single colonies and allowed to grow 
overnight in a 30°C incubator set to 250 RPM. The two cultures with the highest optical density (OD) at 
600 nm were transferred to 100 mL cultures and again grown overnight under the same conditions. The 
following night, the culture with the highest OD was transferred in 15 mL aliquots to each of the five 800 
mL cultures and grown overnight. The following morning, the media containing S. cerevisiae was 
centrifuged in 250 mL Beckman bottles in a GSA rotor for 5 minutes at 5,000 RPM. The supernatant was 
decanted and the pellets of S. cerevisiae combined. The combined pellets were resuspended in Buffer 
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TD (100 mM Tris-SO4 and 10 mM DTT, pH 9.4), with 1 mL of Buffer TD for every 0.3 grams of pellet and 
incubated at 30°C for 15 minutes at 100 RPM. The cells were centrifuged for 5 minutes at 5,000 RPM 
and the supernatant decanted. The pellets were resuspended in Buffer SP (20 mM KPO4 and 1.2 M 
sorbitol, pH 7.4) to remove DTT, before being pelleted again. The pellets were resuspended in 1 mg/mL 
of Zymolase in Buffer SP, with 2 mg of Zymolase for every gram of cells. The cells were incubated at 37°C 
for 37 minutes at 125 RPM to allow for cell wall digestion. The solutions were tested for the formation 
of spheroplasts before proceeding. After spheroplast formation, all steps were performed on ice. 
Spheroplasts were collected by gentle centrifugation at 3.5 RPM for 5 minutes and resuspended in 
Buffer SP. Resuspension and centrifugation was repeated twice more. The spheroplast pellets are 
resuspended in S.E.H. Buffer (250 mM sucrose, 20 mM HEPES, 1 mM EDTA, 0.5% BSA, 1 mM PMSF, 1 
µg/mL Leupeptin, and 1 µg/mL Aprotinin, pH 7.5). Spheroplast solutions are homogenized with a 15 mL 
Dounce homogenizer and homogenized with 15 strokes. Following homogenization, the solutions are 
transferred to 50 mL tubes and centrifuged in a Sorvall SA-600 rotor at 3,500 RPM for 5 minutes. The 
supernatant (Supernatant A) is transferred to new tubes, while the pellets are resuspended 
(Supernatant B) and homogenized again. Supernatant B was centrifuged at 3,500 RPM for 5 minutes and 
the supernatant was then combined with Supernatant A. Combined supernatants were centrifuged at 
10,000 RPM for 10 minutes. The resulting pellets were resuspended in 20 mL of S.E.H. Buffer and 
subjected to two more rounds of slow and fast spins. The final pellets were resuspended in 0.5 mL S.E.H. 












Reduction of Cytochrome C 
 Reduced cytochrome c from Equine heart was prepared by adding 60 mg of cytochrome c to 500 
µL of Assay Buffer (50 mM KPO4 and 50 µM EDTA, pH 7.4). Five mg of Ascorbate was added to reduce 
cytochrome c (28) and was incubated until cytochrome c turned from brown to red. The reduced 
cytochrome c was purified using a Sephadex G25 column equilibrated with Assay Buffer. Fractions were 
collected in 10-drop aliquots and peak fractions were pooled. The concentration of reduced cytochrome 






Transformation of Competent Cells  
 To produce nanodisc scaffolding protein, competent Escherichia Coli BL21 cells were 
transformed with the pET28a-MSP1D1 plasmid by heat shock. The pET28a-MSP1D1 plasmid contains the 
genetic sequence for MSP1E3D1, a variant of membrane scaffolding protein (MSP). The Kan
r-
 gene is 
plasmid-borne on PET28a, allowing transformed cells to grow on YT-Agar media (0.5% (w/v) yeast 
extract, 0.8% (w/v) tryptone, 85.6 mM NaCl and 0.75% (w/v) agar) containing 25 mg/mL Kanamycin.  
 
Overexpression & Induction of Competent Cells 
 Cell cultures were grown in YT media (0.5% (w/v) yeast extract, 0.8% (w/v) tryptone, 85.6 mM 
NaCl, 0.2% (w/v) glucose, and 0.01mg/mL Kanamycin). 5 mL cultures of YT media were inoculated with 
single colonies of transformed cells and incubated for 2 hours (to an OD of 0.3-0.4) at 37°C and 250 
RPM. Cultures that grew the fastest were used to inoculate the four 500 mL cultures of YT media, which 
were grown for 3.5 hours (to an OD of 0.8 to 1.0) at 37°C and 250 RPM. Once an optimal OD was 
reached, MSP expression was induced by adding Isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 1 mM. Cell cultures expressed MSP for 2.5 hours at 26°C and 250 RPM. Following 
induction, cells were pelleted by centrifugation at 5,000 RPM for 20 minutes in a Sorvall GSA rotor. The 
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supernatant was decanted, the pellets flash frozen with liquid nitrogen, and stored at -80°C until needed 
for purification.  
 
Affinity Purification of Membrane Scaffolding Protein 
Pellets were thawed on ice for 15 minutes before being resuspended in Resuspension Buffer (20 
mM NaH2PO4-H2O and 1 mM phenylmethanesulfonylfluoride (PMSF), pH 7.5). Triton X-100 was added to 
the resuspended pellets to a final concentration of 1% (v/v) before cells were disrupted by sonication 
using a Q700 Qsonica sonicator. Cell samples were placed in ice and sonicated at 50% amplitude for five 
rounds (1 minute on, 2 minutes off). Lysed cells were centrifuged in a Sorvall SA-600 rotor at 30,000 g 
for 30 minutes. NaCl was added to the supernatant to a final concentration of 0.3 M before being 
incubated with Ni-NTA from Quiagen, while rotating at 4°C for half an hour, to allow the affinity tag on 
MSP to bind to nickel. The Ni-NTA and supernatant slurry was run through a BioRad Polyprep 
Chromatography Column. The column was washed with increasing concentrations of imidazole (40 mM 
Tris-HCl, 300 mM NaCl, and 0, 20, 50, or 400 mM imidazole, pH 8.0) with each fraction collected as the 
flow through, three washes, or six elution fractions respectively. Samples from each fraction were 
loaded onto a 12.5% SDS-PAGE gel and used to identify peak fractions containing MSP. The peak MSP 
fractions were the first three elution fractions. Fractions containing MSP were added to a 2,000 MWCO 
dialysis cassette from Slide-A-Lyzer and dialyzed against 3 L of Dialysis Buffer (20 mM Tris-HCl, 100 mM 







Purification of Respiratory Complex IV from Isolated Mitochondria  
 All steps were performed on ice or in the cold room at 4°C. 14 to 16 mg of isolated mitochondria 
were first thawed on ice for 40 minutes before being sedimented at 14,000 RPM for 5 minutes. The 
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pellets were resuspended in Resuspension Buffer containing n-Dodecyl β-D-maltoside (DDM) (50 mM 3-
(N-morpholino)propanesulfonic acid (MOPS) and 2% (w/v) DDM, pH 8.0) and incubated for 30 minutes 
to disrupt the mitochondrial membranes. Mitochondrial membrane lipids were pelleted from solution 
by centrifuging the samples at 14,000 RPM and 4°C for 10 minutes. The imidazole concentration of the 
supernatant was brought to 5 mM before incubating with Ni-NTA. The mitochondrial suspension was 
incubated with Ni-NTA agarose for one hour to allow the affinity tag on Cox13 on Complex IV to bind. 
The incubated solution was run through a BioRad Polyprep Chromatography Column. The mitochondrial 
components of the solution that did not have affinity for nickel were eluted from the column in the flow 
through fraction. The column was washed with Wash Buffer (50 mM MOPS, 150 mM NaCl, and 0.009% 
(w/v) DDM, pH 8.0) with increasing concentrations of imidazole (5 or 10 mM) to wash off any protein 
that was nonspecifically bound to column and had low affinity for the matrix. Respiratory Complex IV 
was eluted from the column using Wash Buffer containing increasingly high concentrations of imidazole 
(100, 200 and 300 mM). All fractions were collected and characterized to identify the peak fractions of 
Complex IV using a catalytic activity assay. 
 
Assay of Catalytic Activity of Respiratory Complex IV 
 The redox activity of respiratory Complex IV was quantified colorimetrically by measuring the 
alteration of absorbance of added cytochrome c, which absorbs maximally at 550 nm in the reduced 
form. Time course measurements were conducted using an Ultrospec 2100 pro UV/Visible 
Spectrophotometer from Amersham Biosciences, reading the absorbance at 550 nm in 5-second 
intervals for a total of 180 seconds. The spectrophotometer was blanked with 75 µL of Assay Buffer (50 
mM KPO4 and EDTA, pH 8.0) and 75 µL of the same buffer as the Complex IV sample. The sample used to 
quantify the enzymatic activity was composed of 75 µL of Assay Buffer, 75 µL of Complex IV sample, and 
4 uL of 1700 µM cytochrome c, for a final concentration of 45 µM cytochrome c. The reaction mixture 
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was thoroughly mixed by pipetting up and down seven times, taking approximately 10 seconds, before 
being measured by the spectrophotometer. 
 
Delipidation of Isolated Respiratory Complex IV 
 Peak fractions of Complex IV were pooled and concentrated in a 3,000 MWCO YM-100 Millipore 
concentrator to a final volume of 200-300 µL. Delipidation Buffer (50 mM MOPS, 15.8 mM CaCl2, and 
20% (v/v) glycerol, pH 7.4) was added to the concentrated Complex IV, for a final volume of 1 mL. 10 uL 
of Complex IV in Delipidation Buffer was removed for characterization using a Pierce assay and 
compared to a BSA standard curve to determine the concentration. Porcine phospholipase A2 was 
added to Complex IV in Delipidation Buffer in ten times molar excess to ensure removal of cardiolipin 
from Complex IV. Porcine phospholipase A2 has maximal activity against cardiolipin, cleaving it into 
monolysocardiolipin, which dissociates from Complex IV (29). Work by Sedlak and Robinson (13) has 
shown that the rate of cardiolipin delipidation is dependent on the detergent solubilizing the protein. 
Treatment with Triton X-100 results in the highest rate of delipidation (29). For our purposes, Triton X-
100 is too harsh a detergent for protein purification and would reduce the stability of Complex IV. 
Complex IV was treated with porcine phospholipase A2 for 4 hours at room temperature to ensure the 
cleavage and removal of all endogenous cardiolipin molecules. Porcine phospholipase A2 is calcium 
dependent and the phospholipase was deactivated by the addition of EDTA to a final concentration of 
50 mM. The EDTA was allowed to chelate the calcium in solution for 30 minutes. Following delipidation, 
an activity assay was performed to ensure Complex IV had not degraded. A 50% decrease in the catalytic 






Anion-Exchange Chromatography Purification of Delipidated Complex IV 
 All steps were performed in a cold room at 4°C. A BioRad Column packed with 2 mL of DEAE 
Sepharose CL-6B was equilibrated with 200 mL of Equilibration Buffer (50 mM MOPS and 0.015% (w/v) 
DDM, pH 8.0). Delipidated Complex IV was added to the resin and allowed to flow into the column 
before being washed with Wash Buffer (50 mM MOPS and 0.01% (w/v) DDM, pH 8.0) containing 
increasing concentrations of NaCl (50, 100, 150 mM), not depicted in Figure 6. Complex IV was eluted 
from the column upon washing with Elution Buffer (50 mM MOPS, 0.01% (w/v) DDM, and 500 mM NaCl, 
pH 8.0). Peak fractions were identified using an Activity Assay before being pooled and concentrated to 
500 µL using a 10,000 MWCO YM-100 Millipore concentrator. Porcine phospholipase A2 has a molecular 
weight of 30 kDa, while Complex IV has a molecular weight of 205 kDa, meaning that any phospholipase 
remaining in the peak fractions would be eluted, while all of the Complex IV would be retained in the 
concentrator. 
 
Nanodisc Formation Reaction 
 Lipid blends were prepared by measuring out and drying down POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine) only or BM (40 mole % POPC, 40 mole % POPE (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine), and 20 mole % tetraoleoyl cardiolipin) lipid blends under a nitrogen 
stream for 5 minutes each, before being placed in a desiccator for a minimum of 2 hours. Each lipid 
blend was individually rehydrated in Buffer 2 (20 mM Tris-HCl, 100 mM NaCl, 0.5 mM EDTA, and 59 mM 
Cholate, pH 7.4) and sonicated in a bath sonicator until all of the lipid film was rehydrated in solution. 
The nanodisc components (listed below) were allowed to incubate for 30 minutes at 4°C. The BM 
nanodisc reaction was based on a 143:1 lipid to protein ratio and contained 33 µM BM lipids, 49 µM 
MSP1E3D1, 250 µL of purified lipid-free Complex IV, as well as 20 mM Tris-HCl, 100 mM NaCl, and 0.05 
mM EDTA. The POPC nanodisc reaction was based on a 150:1 lipid to protein ratio and contained 37 µM 
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BM lipids, 49 µM MSP1E3D1, 250 µL of purified lipid-free Complex IV, as well as 20 mM Tris-HCl, 100 
mM NaCl, and 0.08 mM EDTA. Pre-hydrated BioBeads were added to the reaction to remove all 
detergent and initiate nanodisc formation. Previous studies have shown that BioBeads do not absorb a 
significant amount of membrane protein (13). Each nanodisc reaction was incubated at 4°C for 9 hours. 
The nanodiscs were then removed from the BioBeads and incubated with equilibrated Ni-NTA for 45 
minutes at 4°C on a rotator. The incubated nickel beads were poured through a BioRad Polyprep column 
and washed with two column volumes of Wash Buffer (40 mM Tris-HCl and 300 mM NaCl, pH 8.0) 
containing increasing concentrations of imidazole: 0 mM for Wash 1, 20 mM for Wash 2, 50 mM for 
Wash 3, and 400 mM for the Elution. Samples from every fraction were run out on a 12% SDS-PAGE gel 
and stained to determine the location of MSP. Peak fractions were pooled in a 3,000 MWCO Millipore 
concentrator and washed with around 20 mL of Dialysis Buffer (40 mM Tris-HCl and 300 mM NaCl, pH 
7.4) to remove all imidazole from solution. The nanodiscs were concentrated to a final volume of 375 µL. 
 
Complex IV Nanodisc Activity Assay 
 The enzymatic activity of each of the nanodisc samples was quantified by measuring the redox 
activity of the protein through the oxidation of cytochrome c as described above. This was achieved 
through time course measurements using a spectrophotometer, reading the absorbance at 550 nm in 5 
second intervals for a total of 180 seconds. The spectrophotometer was blanked with 75 µL of Assay 
Buffer and 75 µL of Dialysis Buffer. Nanodisc samples contained 75 µL of Assay Buffer, 75 µL of Complex 
IV nanodisc sample, and 27, 32, 37, or 42 µM cytochrome c. One control sample for each nanodisc type 
was incubated with Assay Buffer containing 6 mM KCN. The reaction mixture was thoroughly mixed by 
pipetting up and down seven times before being measured by the spectrophotometer taking 




Dynamic Light Scattering 
 The diameter of nanodisc samples was determined using a Zetasizer Helix from Malvern. BM 
and POPC nanodisc samples were tested to confirm the successful formation of nanodiscs. 
 
Statistical Analysis 
 A two-tailed student’s T-test (unequal variance) was used to determine statistical significance 
(p<0.05) for differences in enzymatic activity. 
 
RESULTS: 
Multiple approaches confirm that nanodiscs containing respiratory Complex IV were successfully 
created. Dynamic Light Scattering showed that nanodiscs of fairly uniform diameter were created and 
constituted the majority of the BM and POPC nanodisc samples (Figure 7). BM nanodiscs were much 
more homogenous than the POPC nanodiscs.  
An attempt was made to identify endogenous lipids that were co-purifying with Complex IV 
using TLC. When the endogenous lipids were extracted from purified Complex IV, the concentration of 
lipids extracted from the protein sample was too low to allow for detection with Molybdenum blue 
spray reagent (Figure not shown). 
The presence of respiratory Complex IV in nanodiscs was confirmed using coomassie staining 
and Western Blotting (Figure 8). The concentration of respiratory Complex IV in the nanodisc 





Figure 7 – Dynamic Light Scattering to Determining the Size of Nanodisc Samples 
The diameter of particles in concentrated nanodisc samples according to the volume of particles at that size. A. 
The distribution of particle sizes in a concentrated BM nanodisc sample. B. The distribution of particle sizes in a 
concentrated POPC nanodisc sample. The data shown is representative of a single trial. 
 
Figure 8 – Elution of Nanodisc Components During Nanodisc Purification 
A. The elution of Respiratory Complex IV throughout the course of the nanodisc purification. The presence of 
Complex IV was determined using anti-Cox4 antibody. Cox4 has a molecular weight of approximately 17 kDa. Key: 
MW – Molecular Weight Ladder, FT – flow through, W1-W3 – Washes 1 through 3, E – pooled elution fractions, C – 
control sample of Complex IV. B. The elution of MSP throughout the course of nanodisc purification. MSP was 
detected through coomassie staining. Key: MW – Molecular Weight ladder, W1-W3 – Washes 1 through 3, E1-E3 – 





Figure 9 – The Catalytic Activity of Respiratory Complex IV Depending on the Duration of Porcine phospholipase 
A2 Treatment Detergent solubilized Complex IV samples were treated with porcine phospholipase A2 for between 
half an hour and four hours before the phospholipase reaction was quenched. The treated Complex IV samples 
underwent an activity assay with 37 µM cytochrome c. 
Complex IV was confirmed in nanodisc samples by Western blotting (Figure 8A), silver staining, and 
SYPRO Orange stain (not shown). The MSP predominantly washes from the affinity column in the first 
two elution fractions, with relatively small amounts of MSP detaching in every fraction except flow 
through. Nanodiscs containing respiratory Complex IV appear to detach from the column during the 
Elution fractions, with a negligible amount of separation occurring during Wash 3.  
To find the optimal incubation period to remove endogenous lipids, DDM solubilized respiratory 
Complex IV was treated with porcine phospholipase A2 for four different periods of time, 0.5 hours, 1 
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hour, 2 hours and 4 hours. After four hours of incubation, there was a noticeable decrease in the 
catalytic activity of Complex IV, associated with the removal of endogenous cardiolipin molecules from 
the protein by phospholipase cleavage of the lipids at the sn-2 position. 
The activity of respiratory Complex IV was measured as oxidation of cytochrome c, therefore 
higher activity is observed as a faster decrease in absorbance of reduced cytochrome c. Complex IV was 
found to be more active in nanodiscs containing cardiolipin (BM), than in nanodiscs that did not contain 
cardiolipin (POPC) (Figure 10). This finding was consistent across all trials, including samples that did not 
undergo phospholipase treatment. Nanodisc samples pretreated with cyanide displayed a total loss of 
catalytic activity by Complex IV, confirming that our measured oxidation of cytochrome c represented 
bona fide Complex IV activity.  
 
Figure 10 – Characterization of the Enzymatic Activity of Respiratory Complex IV in Differing Lipid Environments 
The catalytic activity of Complex IV in nanodiscs containing POPC or a biologically mimetic (BM) lipid blend 
containing POPC, POPE and cardiolipin. Reduced cytochrome c was added to a final concentration of 27 µM to be 
reduced by Complex IV. Activities were fit according to a first-order exponential decay function. Nanodisc samples 




The oxidation of cytochrome c was fit as a first-order exponential decay, with an average R
2
 value of 
0.9996 and a median R
2 
of 0.99991 across all trials. The enzymatic activity can be compared between 
samples using the first order rate constant (k1) constant calculated from the line of best fit, seen as m3 
in Figure 7. In Table 1, the average k values from the line of best fit for each of the lipid blends is 
displayed. For the BM nanodisc samples, the rate constants ranged from 0.037544 to 0.048653 sec
-1
, 
with an average of 0.043019 sec
-1
 across all cytochrome c concentrations. The rate of catalysis 
decreased as the concentration of cytochrome c increases. For the POPC nanodisc samples, the average 
rate constants ranged from 0.003204 to 0.00586 sec
-1
, with an average of 0.004774 sec
-1
 across all of the 
cytochrome c samples. The rate of catalysis did not appear to have a relationship with the concentration 
of cytochrome c. The difference in the rate of Complex IV catalysis between the BM and POPC nanodiscs 
was statistically significant (p<0.05), and was approximately 10 fold greater in BM nanodisc samples 
than in POPC nanodisc samples. There was no statistical difference (p>0.05) between the POPC nanodisc 
samples treated with phospholipase and samples that were not. There was a statistical difference 
(p<0.05) between the BM nanodisc samples treated with phospholipase and samples that were not.  
 
Table 1 – The Average k Value Determined from the Line of Best Fit for Complex IV for Nanodisc Samples  
k values were averaged for every nanodisc trial. Some of the Complex IV samples (POPC – PLA2 and BM – PLA2) 
were not treated with phospholipase A2. All values reported for the average of three trials except POPC, 
determined by the average of two values. 
 
DISCUSSION: 
 Elution of MSP and Complex IV in the elution fractions (Figure 8) shows that the Complex IV is 
properly reconstituted in the nanodiscs and that the nanodiscs are purifying as whole units. Work by the 
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Robinson Group (13, 14) indicates that mammalian subunits COX VIa and VIb dissociate from Complex IV 
upon the removal of the loosely bound cardiolipin molecules. Given that mammalian COX VIa is 
homologous to the yeast subunit Cox13, it is reasonable to assume that upon phospholipase treatment, 
Cox13 would also dissociate. In this experiment, an affinity tag was engineered onto Cox13 to facilitate 
the purification of Complex IV from yeast, meaning that upon treatment with phospholipase, Cox13 and 
the affinity tag located on the C-terminus of the subunit would dissociate. MSP also contains an affinity 
tag to facilitate in the purification of proteins in a model membrane system. The loss of the affinity tag 
on Complex IV elegantly simplifies the purification of nanodiscs containing Complex IV. Each nanodisc 
will only contain a single affinity tag. This simplifies the dissociation of the nanodisc from the nickel 
column because if each nanodisc contained an affinity tag on MSP and Complex IV the dissociation 
would become much more inconsistent, depending on which affinity tag dissociates first. 
MSP1E3D1 nanodiscs have an outer diameter of approximately 12 nm (26). The dynamic light 
scattering measurements (Figure 7) indicate that BM nanodiscs were created with high homogeneity. 
Despite the heterogeneity of the POPC nanodiscs, the nanodiscs had an outer diameter of 
approximately 12 nm, with one population of nanodiscs slightly smaller, one population slightly larger 
and a large diameter contaminant. These dimensions are consistent with a disc that could accommodate 
Complex IV. Respiratory complex IV has a cross sectional area of 7.3 nm by 9.3 nm (25), while MSP1E3D1 
has an inner diameter of 10.8 nm. This allows Complex IV to exist stably in a nanodisc, surrounded by a 
1.5 nm annulus of lipids.  
The difference in activity observed between the BM and POPC nanodiscs shows that cardiolipin 
is playing an important role in the catalytic activity of Complex IV. What was unexpected was the small 
difference in activity of POPC nanodiscs that did and did not undergo phospholipase treatment. 
Respiratory Complex IV should retain the tightly bound cardiolipin molecules when not treated with 
phospholipase, as previous studies have shown that cardiolipin co-purifies with Complex IV (13, 14, 22). 
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Therefore, Complex IV that does not undergo phospholipase treatment should retain the endogenous 
cardiolipin molecules and retain high catalytic activity regardless of the lipid environment. Interestingly, 
when Complex IV was not treated with phospholipase, and was reconstituted into nanodiscs only 
containing POPC, the nanodisc samples displayed similar activity to Complex IV in nanodiscs that did not 
contain any endogenous cardiolipin. The activity of the nanodiscs not treated with phospholipase had k 
values that were 10 times lower than the values of Complex IV in a biomimetic lipid blend. This suggests 
that cardiolipin that is not tightly bound to respiratory Complex IV may play more of a role on the 
catalytic efficiency than previously believed, and may extend beyond the association of a few 
endogenous cardiolipin molecules.  
Recent research investigating supercomplexes in both bovine and yeast models has discovered 
that a large number of cardiolipin molecules, 200 in bovine and 50 in yeast supercomplexes, co-purify 
with the supercomplexes (4). These cardiolipin molecules are too numerous to play a role in the activity 
of the respiratory complexes acting as annular lipids. These cardiolipin molecules likely co-purify 
because they are localized in between the respiratory complexes in the supercomplex. This provides 
some insight into the lipid environment of the respiratory complexes in vivo. This knowledge, in 
conjunction with my findings suggest that cardiolipin molecules also play an important role as bulk 
lipids, lipids in the membrane surrounding a membrane protein that do not directly interface with the 
protein, in the inner mitochondrial membrane. The protein-lipid interaction between cardiolipin and 
Complex IV has never been studied using the nanodisc model membrane system. Previous studies, 
namely the work by the Robinson Group (13, 14), only investigated the activity in detergent solubilized 
micelles. Using detergent solubilization, the only lipids remaining attached to the protein were very 
tightly bound, and for this reason, it is likely that so much emphasis was placed on the tightly bound 
cardiolipin molecules. While it is likely that the endogenous cardiolipin molecules play a vital role in the 
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activity of Complex IV, according to my findings the effect of endogenous cardiolipin is overshadowed by 
the effect of bulk cardiolipin.  
Cytochrome c is believed to interact with cardiolipin through electrostatic interactions by which 
the protein associates with the headgroups of cardiolipin (30). Additionally, cardiolipin may insert one or 
two acyl chains into the hydrophobic pocket of cytochrome c to anchor the protein to the lipid bilayer 
(30). This ability of cardiolipin to interact with cytochrome c and recruit the protein to the inner 
mitochondrial membrane increases the effective concentration of cytochrome c at the interfacial region 
of the bilayer. Increasing the effective concentration of cytochrome c may improve the catalytic activity 
of Complex IV by increasing the availability of cytochrome c for oxidation. Cardiolipin could also play a 
role in the catalytic activity of respiratory Complex IV because of the unique lateral pressure profile that 
the lipid exerts on the membrane. In high concentrations, cardiolipin will assume a non-lamellar phase 
characterized by elongated tubes with the headgroups facing the water-filled center of the tube, and the 
hydrophobic tails facing the outside of the tube. This conformation is known as the hexagonal II phase 
and is observed in lipids composed of acyl chains containing a greater cross-sectional area than the polar 
headgroup. This morphology is likely to be partially responsible for the unique structure of the cristae in 
the inner mitochondrial membrane. The high concentrations of cardiolipin in the inner mitochondrial 
membrane results in a lateral pressure profile unique to the inner mitochondrial membrane. This unique 
lateral pressure profile created by cardiolipin could act on respiratory Complex IV, and force the protein 
to adopt a more active conformation. 
Defects in cardiolipin remodeling are associated with Barth syndrome, a disease marked by the 
enrichment of monolysocardiolipin in the inner mitochondrial membrane (9). Patients suffering from 
this disease exhibit dysfunction in tissues that have high energetic demands such as the heart and other 
muscle tissue. This disease underscores the necessity of cardiolipin for proper mitochondrial activity. 
The experimental findings may have implications into the mechanism by which mitochondrial activity is 
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decreased by an abundance of monolysocardiolipin. Monolysocardiolipin lacks one of acyl chains that 
mature cardiolipin has. This could result in a reduced hex II propensity compared when with mature 
cardiolipin. If Complex IV is squeezed into a more active form by the lateral pressure profile of mature 
cardiolipin, then deviations from this lateral pressure profile could result in a decrease in the efficiency 
of Complex IV activity. Monolysocardiolipin contains one less acyl chain than mature cardiolipin. In 
addition, if cardiolipin inserts one or two acyl chains into the hydrophobic pocket of cytochrome c then a 
decrease in the number of acyl chains could reduce the ability of cytochrome c to associate with the 
membrane, which in turn would reduce the efficiency of Complex IV.  
In future experiments these findings can be further investigated using stopped flow absorbance 
measurements, which would reduce the dead time between the addition of cytochrome c to the 
nanodisc samples and the first reading. A major drawback to this experiment was the uncertainty of the 
time values recorded. The uncertainty caused variation across all samples, preventing the use of more 
widely accepted methods of quantifying enzymatic activity. In these experiments, the dead time was 
approximately 10 seconds. To determine the Michaelis-Menten kinetics of a reaction it will be necessary 
to know the initial rates of the reaction. With the first 10 seconds of the reaction occurring before the 
first reading, the initial reaction velocity data was lost. Attempts were made to extrapolate the initial 
rate of reaction using the line of best fit; however, these data were uncertain and did not fit well enough 
to allow for the determination of Michaelis-Menten constants. With a stopped flow apparatus, the dead 
time would be a few milliseconds and the initial reaction velocity could be observed instead of 
predicted.  
Thin layer chromatography was attempted to identify the presence of endogenous cardiolipin 
molecules. Unfortunately, the cardiolipin molecules were too dilute to detect using molybdenum blue 
spray reagent. A more sensitive method that can be used to detect endogenous cardiolipin molecules is 
mass spectrometry. Using this technique, it is possible to detect how many cardiolipin molecules co-
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purify with Complex IV. Additionally, mass spectrometry could be used to confirm the removal of the 
endogenous cardiolipin molecules upon treatment with phospholipase, as well as the dissociation of 
Cox12 and Cox13 following phospholipase treatment. Having a clear understanding of how many 
cardiolipin molecules co-purify with Complex IV and what treatment is required to remove the 
cardiolipin molecules will provide more insight into the protein-lipid interaction. It is important to know 
that phospholipase treatment is required for the removal of the tightly bound cardiolipin molecules; 
otherwise, the observed effects of cardiolipin in bulk lipids are not valid. These experiments are 
currently underway in our group. 
Diseases associated with dysfunctional lipid biosynthesis, such as Barth syndrome, can be 
studied in the future through the creation of nanodiscs using different lipid blends. Nanodiscs enriched 
in monolysocardiolipin rather than mature cardiolipin could be used to simulate the lipid environment 
of the inner mitochondrial membrane for an individual suffering from Barth syndrome. Deoxy-
cardiolipin, cardiolipin molecule lacking the central hydroxyl group from the linking glycerol, could be 
used in place of cardiolipin to probe the influence of the endogenous cardiolipin molecules and the 
function they play as proton antennas for the D-channel. 
The mechanism by which the effect of cardiolipin in the bulk lipids can be investigated in future 
experiments by replacing cytochrome c with an electron carrier that does not have the same propensity 
to interact with lipids. If cardiolipin is recruiting cytochrome c to improve the activity of Complex IV then 
there should be no difference between the catalytic activity of Complex IV in nanodiscs containing 
cardiolipin and nanodiscs lacking cardiolipin. The effect of the lateral pressure profile of cardiolipin on 
Complex IV can be elucidated using lipids that display a lateral pressure profile similar to cardiolipin. If 
cardiolipin was replaced by another lipid, which favors the hexagonal II conformation, then there should 
be no difference in the catalytic activity of Complex IV if the lateral pressure profile of cardiolipin causes 
Complex IV to adopt a more catalytically active conformation.  
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In conclusion, this study has shown that cardiolipin is required for the proper activity of 
respiratory Complex IV and for the first time suggested a role of cardiolipin in the bulk lipids of the inner 
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